Abstrakt

The aim of the follow-up study was to compare the changes of M-mode echocardiographic parameters in autosomal dominant polycystic kidney disease (ADPKD) patients and controls without renal failure during six years of observation and to explore the associations of these parameters with metabolic syndrome components and kidney function. We performed a follow-up examination in 37 ADPKD patients and 40 controls. Anthropometric parameters were measured and fasting venous blood sample from each patient was tested for glucose, insulin, C-peptide, HbA1c, creatinine, and urea concentrations. All subjects underwent standard two-dimensional M-mode echocardiography. Left ventricular hypertrophy (LVH) was diagnosed based on left ventricular mass index (LVMI) adjusted for body surface area (LVMI- -S, LVH-S) or for height (LVMI-H, LVH-H). The prevalence of LVH was significantly greater in ADPKD patients than in controls (35% vs. 10%, p=0.012) according to the ESH/ESC criteria from 2013, and (27.0% vs. 7.5%, p=0.032) according to criteria from 2017. In patients with ADPKD, no significant increase of the echocardiographic parameters was observed in the 6 years between the initial examination and the follow-up examination. Cardiac involvement in women with ADPKD occurs at an earlier stage of the disease than in men. In patients with ADPKD treated for hypertension in accordance with the 2013 ESH/ESC Guidelines the progression of LVH was not observed during the 6-year follow-up, despite the deterioration of renal function. Obesity, blood pressure and renal function do not affect LVMI changes.

Przypisy

• 1. Abbasi F., Reaven G.M.: Evaluation of the quantitative insulin sensitivitycheck index as an estimate of insulin sensitivity in humans.Metabolism, 2002; 51: 235–237
  Google Scholar
• 2. Bardají A., Vea A.M., Gutierrez C., Ridao C., Richart C., Oliver J.A.:Left ventricular mass and diastolic function in normotensive youngadults with autosomal dominant polycystic kidney disease. Am.J. Kidney Dis., 1998; 32: 970–975
  Google Scholar
• 3. Chapman A.B., Johnson A.M., Rainguet S., Hossack K., Gabow P.,Schrier R.W.: Left ventricular hypertrophy in autosomal dominantpolycystic kidney disease. J. Am. Soc. Nephrol., 1997; 8: 1292–1297
  Google Scholar
• 4. Chen H., Watnick T., Hong S.N., Daly B., Li Y., Seliger S.L.: Left ventricularhypertrophy in a contemporary cohort of autosomal dominantpolycystic kidney disease patients. BMC Nephrol., 2019; 20: 386
  Google Scholar
• 5. de Almeida E.A., de Oliveira E.I., Lopes J.A., Almeida A.G., LopesM.G., Prata M.M.: Ambulatory blood pressure measurement in youngnormotensive patients with autosomal dominant polycystic kidneydisease. Rev. Port. Cardiol., 2007; 26: 235–243
  Google Scholar
• 6. Ecder T.: Cardiovascular complications in autosomal dominantpolycystic kidney disease. Curr. Hypertens. Rev., 2013; 9: 2–11
  Google Scholar
• 7. Ecder T., Edelstein C.L., Chapman A.B., Johnson A.M., Tison L., GillE.A., Brosnahan G.M., Schrier R.W.: Reversal of left ventricular hypertrophywith angiotensin converting enzyme inhibition in hypertensivepatients with autosomal dominant polycystic kidney disease.Nephrol. Dial. Transplant., 1999; 14: 1113–1116
  Google Scholar
• 8. Ecder T., Schrier R.W.: Hypertension in autosomal-dominant polycystickidney disease: Early occurrence and unique aspects. J. Am. Soc.Nephrol., 2001; 12: 194–200
  Google Scholar
• 9. Ecder T., Schrier R.W.: Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat. Rev. Nephrol., 2009;5: 221–228
  Google Scholar
• 10. Hanaoka K., Qian F., Boletta A., Bhunia A.K., Piontek K., TsiokasL., Sukhatme V.P., Guggino W.B., Germino G.G.: Co-assembly of polycystin- 1 and -2 produces unique cation-permeable currents. Nature,2000; 408: 990–994
  Google Scholar
• 11. Idrizi A., Barbullushi M., Strakosha A., Kodra S., Thereska N., ZaimiE., Gjyzari A., Petrela E.: The relation of hypertension, renal functionand cardiovascular events in autosomal dominant polycystic kidneydisease. G. Ital. Nefrol., 2007; 24: 595–599
  Google Scholar
• 12. Ivy D.D., Shaffer E.M., Johnson A.M., Kimberling W.J., Dobin A.,Gabow P.A.: Cardiovascular abnormalities in children with autosomaldominant polycystic kidney disease. J. Am. Soc. Nephrol., 1995;5: 2032–2036
  Google Scholar
• 13. Joly D., Hummel A., Ruello A., Knebelmann B.: Ciliary function ofpolycystins: A new model for cystogenesis. Nephrol. Dial. Transplant.,2003; 18: 1689–1692
  Google Scholar
• 14. Kimberling W.J., Kumar S, Gabow P.A., Kenyon J.B., Connolly C.J.,Somlo S.: Autosomal dominant polycystic kidney disease: Localizationof the second gene to chromosome 4q13-q23. Genomics, 1993;18: 467–472
  Google Scholar
• 15. Lai S., Mastroluca D., Matino S., Panebianco V., Vitarelli A., CapotostoL., Turinese I., Marinelli P., Rossetti M., Galani A., BaiocchiP., D’Angelo A.R., Palange P.: Early markers of cardiovascular risk inautosomal dominant polycystic kidney disease. Kidney Blood Press.Res., 2017; 42: 1290–1302
  Google Scholar
• 16. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F. 3rd,Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., CoreshJ., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration):A new equation to estimate glomerular filtration rate. Ann. Intern.Med., 2009; 150: 604–612]
  Google Scholar
• 17. Levy J.C., Matthews D.R., Hermans M.P.: Correct homeostasismodel assessment (HOMA) evaluation uses the computer program.Diabetes Care, 1998; 21: 2191–2192
  Google Scholar
• 18. Lumiaho A., Pihlajamäki J., Hartikainen J., Ikäheimo R., MiettinenR., Niemitukia L., Lampainen E., Laakso M.: Insulin resistance is relatedto left ventricular hypertrophy in patients with polycystic kidneydisease type 1. Am. J. Kidney Dis., 2003; 41: 1219–1224
  Google Scholar
• 19. Mao Z., Xie G., Ong A.C.: Metabolic abnormalities in autosomaldominant polycystic kidney disease. Nephrol. Dial. Transplant., 2015;30: 197–203
  Google Scholar
• 20. Martinez-Vea A., Valero F.A., Bardaji A., Gutierrez C., Broch M.,Garcia C., Richart C., Oliver J.A.: Left ventricular hypertrophy in hypertensivepatients with autosomal dominant polycystic kidney disease:Influence of blood pressure and humoral and neurohormonal factors.Am. J. Nephrol., 2000; 20: 193–200
  Google Scholar
• 21. Paavola J., Schliffke S., Rossetti S., Kuo I.Y., Yuan S., Sun Z., HarrisP.C., Torres V.E., Ehrlich B.E.: Polycystin-2 mutations lead to impairedcalcium cycling in the heart and predispose to dilated cardiomyopathy.J. Mol. Cell. Cardiol., 2013; 58: 199–208
  Google Scholar
• 22. Perrone R.D., Abebe K.Z., Schrier R.W., Chapman A.B., Torres V.E.,Bost J., Kaya D., Miskulin D.C., Steinman T.I., Braun W., Winklhofer F.T.,Hogan M.C., Rahbari-Oskoui F., Kelleher C., Masoumi A., et al.: Cardiacmagnetic resonance assessment of left ventricular mass in autosomaldominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol.,2011; 6: 2508–2515
  Google Scholar
• 23. Pietrzak-Nowacka M., Safranow K., Bober J., Olszewska M., BirkenfeldB., Nowosiad M., Ciechanowski K.: Calcium-phosphate metabolismparameters and erythrocyte Ca2+ concentration in autosomal dominantpolycystic kidney disease patients with normal renal function.Arch. Med. Sci., 2013; 9: 837–842
  Google Scholar
• 24. Pietrzak-Nowacka M., Safranow K., Czechowska M., DutkiewiczG., Kornacewicz-Jach Z., Ciechanowski K.: Autosomal dominant polycystickidney disease and hypertension are associated with left ventricularmass in a gender-dependent manner. Kidney Blood Press.Res., 2012; 36: 301–309
  Google Scholar
• 25. Ravine D., Gibson R.N., Walker R.G., Sheffield L.J., Kincaid–SmithP., Danks D.M.: Evaluation of ultrasonographic diagnostic criteria forautosomal dominant polycystic kidney disease 1. Lancet, 1994; 343:824–827
  Google Scholar
• 26. Rostoff P., Gackowski A., Nessler J., Piwowarska W.: Left ventricularhypertrophy – current views on the pathophysiology, associationwith cardiovascular risk, and therapeutic options. Kardiol. Pol.,2010; 68: 815–823
  Google Scholar
• 27. The polycystic kidney disease 1 gene encodes a 14 kb transcriptand lies within a duplicated region on chromosome 16. The EuropeanPolycystic Kidney Disease Consortium. Cell, 1994; 77: 881–894
  Google Scholar
• 28. Timio M., Monarca C., Pede S., Gentili S., Verdura C., Lolli S.: Thespectrum of cardiovascular abnormalities in autosomal dominantpolycystic kidney disease: A 10-year follow-up in a five-generationkindred. Clin. Nephrol., 1992; 37: 245–251
  Google Scholar
• 29. Valero F.A., Martinez-Vea A., Bardají A., Gutierrez C., Garcia C.,Richart C., Oliver J.A.: Ambulatory blood pressure and left ventricularmass in normotensive patients with autosomal dominant polycystickidney disease. J. Am. Soc. Nephrol., 1999; 10: 1020–1026
  Google Scholar
• 30. Zeier M., Geberth S., Schmidt K.G., Mandelbaum A., Ritz E.: Elevatedblood pressure profile and left ventricular mass in childrenand young adults with autosomal dominant polycystic kidney disease.J. Am. Soc. Nephrol., 1993; 3: 1451–1457
  Google Scholar

Pełna treść artykułu